Sailaja Kamaraju

Also affiliated with University of Wisconsin–Milwaukee, Medical College of Wisconsin Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer”.

Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer

Genome Medicine(2024)10.1186/s13073-024-01407-3

N/A

0.678DataRank · unranked

29 citations

Aigbe G. Ohihoin, Tianxiang Liu, Lavanya Choppavarapu, Bakhtiyor Nosirov, Qianben Wang +5 more

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07038-3

N/A

0.545DataRank · unranked

10 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

Equitable community-based participatory research engagement with communities of color drives All of Us Wisconsin genomic research priorities

Journal of the American Medical Informatics Association(2024)10.1093/jamia/ocae265

N/A

0.208DataRank · unranked

3 citations

Xin Yang, Paramita Basak Upama, Aziz Abdullah, Shary Pérez Torres, Linda Jackson Cocroft +10 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13103

N/A

0.208DataRank · unranked

3 citations

Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn, Frederick M. Howard +8 more

Attribution of symptoms to adjuvant endocrine therapy and association with adherence among older women with breast cancer: A qualitative study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e24086

N/A

0.128DataRank · unranked

1 citations

Anna Lyons, Sailaja Kamaraju, Melinda Stolley, Joan Neuner, Kathryn E. Flynn +1 more

Aromatase Inhibitor Symptom Management Practices: A Retrospective Study

Clinical Breast Cancer(2020)10.1016/j.clbc.2020.07.008

N/A

0DataRank · unranked

7 citations

Kathryn E. Flynn, Elizabeth Weil, Bradley H. Crotty, Sailaja Kamaraju, Nicole Fergestrom +2 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07626-5

N/A

0DataRank · unranked

2 citations

Margarite D. Matossian, Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn +8 more

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy

Research Square(2023)10.21203/rs.3.rs-2777910/v1

N/A

0DataRank · unranked

2 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients

Annals of Surgical Oncology(2024)10.1245/s10434-024-15319-4

N/A

0DataRank · unranked

8 citations

Samuel Lawton, Sailaja Kamaraju, Melinda Stolley, Andrew E. Petroll, Chandler S. Cortina +1 more

An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer

Current Oncology Reports(2024)10.1007/s11912-024-01525-6

N/A

0DataRank · unranked

1 citations

June M. McKoy, Grant R. Williams, Nikesha Gilmore, Christina A. Minami, Kathryn Bylow +8 more

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07750-2

N/A

0DataRank · unranked

5 citations

Christine C Rogers, Jan Irene Lloren, Sailaja Kamaraju, Lubna N. Chaudhary, Chiang‐Ching Huang +6 more